Jang Bahadur Gupta

This inventor holds 15 USPTO granted patents, primarily in Muscarinic Receptor Antagonists. Top assignees: Ranbaxy Laboratories, Inc., Other. Active years: 2002-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jang Bahadur Gupta. Retrieved from https://idiyas.com/inventor/jang-bahadur-gupta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 20.0

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 36(Granted Patents)

Location History:

New Delhi, IN (2002)
Gurgaon, IN (2003 - 2006)
Haryana, IN (2005 - 2008)
Dusseldorf, DE (2007 - 2009)
Hyogo, JP (2009)

Company Filing History:

14 out of 157

Ranbaxy Laboratories, Inc.

patents

1 out of 834,601

Other

patents

Years Active: 2002-2009

Loading Chart...

Areas of Expertise:

Muscarinic Receptor Antagonists

Azabicyclo Derivatives

Flavaxate Derivatives

Pyrrolidine Derivatives

Cell Adhesion Inhibitors

Piperazine Derivatives

Uro-Selective Blockers

Disubstituted Compounds

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7592359 - Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists (2009-09-22),

2. 7517905 - Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists (2009-04-14),

3. 7501443 - Flavaxate derivatives as muscarinic receptor antagonists (2009-03-10),

4. 7488748 - 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists (2009-02-10),

5. 7465751 - 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists (2008-12-16),

6. 7410993 - 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists (2008-08-12),

7. 7399779 - 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists (2008-07-15),

8. 7288562 - Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists (2007-10-30),

9. 7265147 - 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists (2007-09-04),

10. 7232835 - 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists (2007-06-19),

11. 7037899 - Derivatives of monosaccharides as cell adhesion inhibitors (2006-05-02),

12. 7005422 - Derivatives of monosaccharides as cell adhesion inhibitors (2006-02-28),

13. 6914064 - 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers (2005-07-05),

14. 6590085 - Derivatives of monosaccharides as cell adhesion inhibitors (2003-07-08),

15. 6420366 - 1-(4-arylpiperazin-1-yl)-&ohgr;-[N-(&agr;&ohgr;-dicarboximido)]-alkanes useful as uro-selective &agr;1-adrenoceptor blockers (2002-07-16),

Title: Jang Bahadur Gupta - Innovative Inventor from Dusseldorf

Introduction: Jang Bahadur Gupta is a renowned inventor based in Dusseldorf, Germany, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Gupta's latest patents include a revolutionary renewable energy device that harnesses solar power more efficiently and a cutting-edge medical device for non-invasive diagnostics.

Career Highlights: With over two decades of experience in the industry, Gupta has a proven track record of developing innovative solutions that have significantly impacted the fields of clean energy, healthcare, and telecommunications.

Collaborations: Gupta has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His collaborative efforts have resulted in several successful commercial products that have improved the quality of life for many.

Conclusion: Jang Bahadur Gupta's relentless pursuit of innovation and his passion for creating solutions to complex challenges have established him as a prominent figure in the world of inventors. His dedication to pushing the boundaries of technology continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]